Skip to main content
春光智能 logo

春光智能 — Investor Relations & Filings

Ticker · 920810 Beijing Stock Exchange Manufacturing
Filings indexed 329 across all filing types
Latest filing 2024-11-26 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920810

About 春光智能

http://www.lncgjx.com/

Chunguang Intelligent specializes in the research, development, and manufacturing of high-performance components for cleaning appliances. The company primarily focuses on flexible hoses, floor brush assemblies, and extension tubes designed for vacuum cleaners and floor scrubbers. By leveraging advanced polymer material technology and integrated production processes, it provides customized solutions to leading global household appliance brands. Its product portfolio includes various hose types such as PVC, EVA, and wire-reinforced structures, emphasizing durability and flexibility. The company maintains a strong focus on technical innovation and quality control to meet the evolving demands of the smart cleaning sector.

Recent filings

Filing Released Lang Actions
独立董事候选人声明与承诺(房华)
Regulatory Filings Classification · 95% confidence The document is a declaration and commitment statement by an independent director candidate (房华) for a company listed on the Beijing Stock Exchange. It details the candidate's qualifications, compliance with relevant laws and regulations, independence criteria, and commitments during the tenure. There is no financial data, no report or announcement of financial results, no voting results, no management changes, or other typical financial or regulatory filings. The document is a regulatory compliance statement related to board candidate qualifications and independence, which does not fit into categories like Annual Report, Interim Report, or Management Reports. It is not a report publication announcement or a certification letter but a formal regulatory filing about director candidacy and compliance. Therefore, the best fitting category is Regulatory Filings (RNS). The document length is 2561 characters, which is relatively short but contains substantive content about regulatory compliance rather than a mere announcement.
2024-11-26 Chinese
第三届监事会第十七次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a meeting resolution announcement from the Supervisory Board of Liaoning Chunguang Pharmaceutical Equipment Co., Ltd. It details the meeting date, attendance, and the approval of a proposal regarding the company's 2024 third quarter report. The actual 2024 third quarter report is referenced as being published separately on the official exchange platform (Beijing Stock Exchange) with a different announcement number. The document itself does not contain the financial data or substantive analysis of the quarterly report but only announces the meeting decision and voting results. The document length is short (738 characters), and it serves as an announcement of a meeting resolution and reference to the quarterly report rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and meeting resolution notice, not as an Interim/Quarterly Report (IR).
2024-10-27 Chinese
关于公司拟向银行申请授信的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's plan to apply for a bank credit facility. It details the loan amount, terms, board approval, and necessity of the loan. There is no financial report, earnings data, or audit information presented. The document is a financing update about the company's capital activities, specifically a credit application. It is not a full financial report or regulatory certification. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content support this classification with high confidence.
2024-10-27 Chinese
第三届董事会第三十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 30th meeting of the third board of directors of Liaoning Chunguang Pharmaceutical Equipment Co., Ltd. It details the meeting's attendance, the agenda items discussed, and the voting results. The document references other announcements for the 2024 third quarter report and a bank credit application but does not contain the reports themselves. The content focuses on board meeting decisions and approvals, which aligns with Board/Management Information filings. The document length is short (1121 characters), and it is not a full financial report or earnings release. Therefore, the appropriate classification is Board/Management Information (MANG).
2024-10-27 Chinese
2024年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "辽宁春光制药装备股份有限公司 2024 年三季度报告" which translates to "Liaoning Chunguang Pharmaceutical Equipment Co., Ltd. 2024 Third Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and explanations of financial changes for the third quarter of 2024. The document explicitly states it is a quarterly report (三季度报告) and includes comprehensive financial statements and management commentary on financial performance. It is unaudited, which is common for interim/quarterly reports. The length of the document (15,000 characters) and the detailed financial data confirm it is a full interim/quarterly report rather than a brief announcement or a certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2024
2024-10-27 Chinese
关于募集资金使用完毕并注销募集资金专项账户的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the completion of the use of raised funds and the cancellation of the related fundraising accounts. It details the fundraising approval, amount raised, management of the funds, and the account cancellation status. There are no financial statements or detailed financial performance data included. The document is relatively short (1517 characters) and serves as a formal notification about the fundraising completion and account closure. This fits the category of Capital/Financing Update (CAP) rather than a full financial report or audit report.
2024-09-29 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.